We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
ADLM 2025
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Rapid Influenza Test Evaluated for Children

By LabMedica International staff writers
Posted on 24 May 2011
A rapid influenza assay has been evaluated for use with elementary school children and compared with a molecular test.

The test is a lateral-flow immunoassay that uses monoclonal antibodies specific for influenza viral nucleoprotein antigens and detects and differentiates between influenza A and B.

Public Health specialists at the University of Pittsburgh, (Pittsburgh, PA, USA), collected 278 pairs of nasal swabs from children during home visits during the 2007-2008 influenza season. One swab was tested with the immunoassay, which takes 10 minutes or less, and the other with a real time, reverse transcriptase polymerase chain reaction (RT-PCR). A total of 104 samples were positive by RT-PCR test, and of these, 54/104 (52%) were influenza A and 50/104 (48%) were influenza B.

Only 28/104 (27%), of these influenza-positive samples were detected as positive by QuickVue rapid immunoassay influenza testing. Influenza A accounted for 17 (61%) of the 28 positive tests, and of the remaining 11 (39%) were influenza B. The sensitivity and specificity of rapid influenza testing, using the QuickVue Influenza A+B test (Quidel; San Diego, CA, USA), in the students with influenza like illness who were tested was 27% (28/104) and 97% (168/174), respectively. The overall positive predictive value was 82% (28/34) and 69% (168/244) for negative predictive values. There was no statistically valid correlation between the semiquantitative PCR result and the QuickVue result.

The authors concluded that community testing includes patients who represent the entire spectrum of illness, with the majority exhibiting mild to moderate symptoms and not requiring medical attention. Viral load, technique, and the use of nasal swabs were examined as contributing factors to the low sensitivity of the QuickVue test, but were not found to be explanations for this result. If tests with higher sensitivities in community settings were available, they could be used as a part of an improved surveillance and early warning system for influenza activity and rapid confirmation of outbreaks. The study was published in March 2011, in the journal Influenza and Other Respiratory Viruses.

Related Links:

University of Pittsburgh
Quidel




New
Gold Member
Hematology Analyzer
Medonic M32B
Serological Pipet Controller
PIPETBOY GENIUS
New
Specimen Radiography System
TrueView 200 Pro
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control

Latest Microbiology News

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance
24 May 2011  |   Microbiology

Early Detection of Gut Microbiota Metabolite Linked to Atherosclerosis Could Revolutionize Diagnosis
24 May 2011  |   Microbiology

Viral Load Tests Can Help Predict Mpox Severity
24 May 2011  |   Microbiology



PURITAN MEDICAL